Spruce Biosciences at H.C. Wainwright: BLA path comes into focus
The regulatory picture changed in February 2024, when the FDA held a Reagan-Udall Foundation forum on neuronopathic mucopolysaccharidoses.
- About
-
Projects
-
Column 1
- Advancing Regulatory Science
- Animal Health & Veterinary Medicine
- Expanded Access
- FDA Patient Listening Sessions
-
Column 2
- Food & Nutrition
- Improving Access to FDA Information
- Research
- Substance Use Disorders
-
Column 1
- News and Events
- Expanded Access eRequest